Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BOTULINUM TOXIN TYPE A: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

78.8%
Female
21.2%
Male

Age Information

The average age of patients reporting adverse events with BOTULINUM TOXIN TYPE A is 44.1 years.

Geographic Distribution

The majority of adverse event reports for BOTULINUM TOXIN TYPE A originate from CA.

Report Summary & Outcomes

3,742
Total Reports
3,742
As Primary/Secondary Suspect
1,288
Deaths Reported
1,536
Hospitalizations
1,116
Life-Threatening
1,150
Disabilities

Reporting Timeline

First adverse event report: 19930101. Most recent report: 20250905. View full timeline →

More About BOTULINUM TOXIN TYPE A

BOTULINUM TOXIN TYPE A Full Profile Reports by Year Drug Interactions